Next Article in Journal
Improved Photodynamic Therapy of Hepatocellular Carcinoma via Surface-Modified Protein Nanoparticles
Previous Article in Journal
The Influence of Indisulam on Human Immune Effector Cells: Is a Combination with Immunotherapy Feasible?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 17
Issue 3
10.3390/pharmaceutics17030369
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceutics 2022, 14(5), 925.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Kuskov et al. Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study. Pharmaceutics 2022, 14, 925

by
Andrey Kuskov
1,2,
Dragana Nikitovic
3,*,
Aikaterini Berdiaki
3,
Mikhail Shtilman
2 and
Aristidis Tsatsakis
4
1
Department of Technology of Chemical Pharmaceutical and Cosmetic Substances, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia
2
Department of Biomaterials, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia
3
Laboratory of Histology-Embryology, Medical School, Voutes Campus, University of Crete, 71003 Heraklion, Greece
4
Center of Toxicology Science & Research, Division of Morphology, Medical School, Voutes Campus, University of Crete, 71003 Heraklion, Greece
*
Author to whom correspondence should be addressed.
Pharmaceutics 2025, 17(3), 369; https://doi.org/10.3390/pharmaceutics17030369
Submission received: 3 March 2025 / Accepted: 7 March 2025 / Published: 14 March 2025
Browse Figure
Versions Notes
Error in Figure
In the original publication [1], there was a mistake in Figure 7 as published. The wrong image for Figure 7A was included. The corrected Figure 7 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Pharmaceutics 17 00369 g007
Figure 7. The effect of free and loaded to PVP-OD4000 IMC oral administration on rat stomach mucosa. (A) Hollow PVP-OD4000; (B) free IMC 40 mg/kg BW); (C) IMC loaded to PVP-OD4000 40 mg/kg BW; (D) IMC loaded to PVP-OD4000 60 mg/kg BW.
Figure 7. The effect of free and loaded to PVP-OD4000 IMC oral administration on rat stomach mucosa. (A) Hollow PVP-OD4000; (B) free IMC 40 mg/kg BW); (C) IMC loaded to PVP-OD4000 40 mg/kg BW; (D) IMC loaded to PVP-OD4000 60 mg/kg BW.
Pharmaceutics 17 00369 g007

Reference

  1. Kuskov, A.; Nikitovic, D.; Berdiaki, A.; Shtilman, M.; Tsatsakis, A. Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study. Pharmaceutics 2022, 14, 925. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kuskov, A.; Nikitovic, D.; Berdiaki, A.; Shtilman, M.; Tsatsakis, A. Correction: Kuskov et al. Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study. Pharmaceutics 2022, 14, 925. Pharmaceutics 2025, 17, 369. https://doi.org/10.3390/pharmaceutics17030369

AMA Style

Kuskov A, Nikitovic D, Berdiaki A, Shtilman M, Tsatsakis A. Correction: Kuskov et al. Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study. Pharmaceutics 2022, 14, 925. Pharmaceutics. 2025; 17(3):369. https://doi.org/10.3390/pharmaceutics17030369

Chicago/Turabian Style

Kuskov, Andrey, Dragana Nikitovic, Aikaterini Berdiaki, Mikhail Shtilman, and Aristidis Tsatsakis. 2025. "Correction: Kuskov et al. Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study. Pharmaceutics 2022, 14, 925" Pharmaceutics 17, no. 3: 369. https://doi.org/10.3390/pharmaceutics17030369

APA Style

Kuskov, A., Nikitovic, D., Berdiaki, A., Shtilman, M., & Tsatsakis, A. (2025). Correction: Kuskov et al. Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study. Pharmaceutics 2022, 14, 925. Pharmaceutics, 17(3), 369. https://doi.org/10.3390/pharmaceutics17030369

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop